Monohydrido-bridged ruthenium complex [{(η-p-cymene)RuCl}(μ-H-μ-Cl)] catalyzes (catalyst load: 0.5-1 mol %) α-selective deuteration of primary and secondary amines, amino acids, and drug molecules using deuterium oxide (DO) as a deuterium source. Mechanistic investigations revealed N-H activation of amines, which was also established by single-crystal X-ray analysis of an intermediate. β-Hydride elimination on amide ligand results in formation of imine-ligated ruthenium intermediate and subsequent 1,3-deuteride migrations to imine ligand leading to the selective deuteration at the α-CH protons of amine functionality is proposed.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1021/acs.orglett.6b02978 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!